Oric Pharmaceuticals, Inc. (ORIC)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Oric Pharmaceuticals, Inc. (ORIC)
Go deeper and ask any question about ORIC
Company Performance
Current Price
as of Sep 17, 2024$10.10
P/E Ratio
N/A
Market Cap
$712.48M
Description
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
Metrics
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerORIC
- Price$10.1+1.10%
Trading Information
- Market Cap$712.48M
- Float65.63%
- Average Daily Volume (1m)394,314
- Average Daily Volume (3m)571,216
- EPS-$1.76
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$31.96M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$35.75M
- EV$213.73M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account